Physician profile
Lacey D Clawson
NPI 1497986202
$11,773.18
in general payments reported to CMS, 2019-2025
30 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2021: $306 · 2022: $9,687 · 2023: $379 · 2024: $114 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,828.34 | 2022 | |
| Pylant Medical | $2,160.76 | 2021-2025 | |
| Stryker Corporation | $237.56 | 2025 | Infinity, Augment Injectable, Axs Infinity Ls |
| Bioventus LLC | $168.68 | 2021-2025 | Exogen Ultrasound Bone Healing System, Xcell, Durolane |
| Zimmer Biomet Holdings, INC. | $143.15 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $136.89 | 2025 | |
| Ferring Pharmaceuticals INC. | $133.11 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $128.49 | 2023-2025 | Va-Lcp, Na, Hammerlock |
| Amgen INC. | $110.40 | 2025 | Krystexxa |
| Argentum Medical | $105.86 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $102.38 | 2022-2025 | Exparel, Iovera, Zilretta |
| Smith+Nephew, INC. | $65.00 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Anika Therapeutics, INC. | $48.99 | 2021-2022 | |
| Hydrocision, INC. | $45.14 | 2022 | |
| Abbott Laboratories | $35.57 | 2023 | Proclaim |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $34.19 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kowa Pharmaceuticals America, INC. | $32.91 | 2022 | |
| Abbvie INC. | $30.02 | 2025 | |
| Innovation Technologies INC | $23.52 | 2023 | Irrisept |
| Globus Medical, INC. | $23.16 | 2023 | Troch Nail |
| Molnlycke Health Care US, LLC | $23.07 | 2025 | Mepilex Border Post-Op Ag |
| Treace Medical Concepts, INC. | $22.48 | 2024 | |
| Mimedx Group, INC. | $21.44 | 2025 | |
| Curonix LLC | $19.67 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Davol INC. | $19.13 | 2025 | Surgiphor |
| Organogenesis INC. | $17.70 | 2025 | Puraply Wound Matrix |
| Pacira Therapeutics, INC. | $17.48 | 2021 | |
| Tactile Systems Technology INC | $15.76 | 2019 | |
| Orthofix Medical, INC. | $14.30 | 2025 | Physio-Stim |
| Advanced Oxygen Therapy INC. | $8.03 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Clawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.